Please login first

Non-Coding RNA Webinar| From MicroRNA Biology to Clinical Breakthroughs: Advancing MicroRNAs as Anti-Cancer Agents

Part of the Non-Coding RNA Journal Webinar series
9 September 2025, 17:00 (CEST)

Registration Deadline
9 September 2025

miRNA, Therapy, Cancer, Drug, Backbone modification, miR-34a
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Event Registration Contact Us

Welcome from the Chair

The Non-coding RNA journal webinar is open to all who enjoy doing any type of research on the topic of non-coding transcripts or are passionate about learning about this exciting and competitive research area. The webinar speakers will present new findings from basic to translational research. Any interesting ideas for topics and speakers are welcomed!

Date: 09 September 2025
Time: : 5:00 p.m. CET | 11:00 a.m. EDT
Webinar ID: 849 1920 8776
Webinar Secretariat: journal.webinar@mdpi.com

Event Chair

Institute of Clinical Physiology (IFC), National Research Council (CNR) and Oncogenomics Unit, Core Research Laboratory (CRL), Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Via Moruzzi 1, 56124 Pisa, Italy

Introduction
Bio
Dr. Poliseno graduated in Biological Sciences in 2000 and got her PhD in Molecular Biotechnology in 2004, both at University of Pisa, Italy. In 2006, she moved to the US, where she became a post-doctoral fellow in the laboratory of Prof. Pier Paolo Pandolfi, first at MSKCC in New York and then at BIDMC-HMS in Boston. In 2009, she started a second post-doc in the lab of Prof. Iman Osman at NYU. In 2012, she was appointed as Principal Investigator of the Oncogenomics Unit of ITT (now ISPRO) and in 2016 she became Staff Scientist at the Institute of Clinical Physiology of the National Research Council in Pisa, Italy, where her lab is located. Throughout her scientific career, Dr. Poliseno’s research interests have mostly revolved around non-coding RNAs (microRNAs, pseudogenes, ceRNAs) in cancer. Currently, the activities of the Poliseno lab are focused on the coding and non-coding regulatory networks of BRAFV600E isoforms in melanoma. They are also developing strategies for the selective delivery of drug combinations inside cancer cells, exploiting the attenuated bacterium Listeria monocytogenes.

Invited Speaker

Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA,
Purdue Institute for Cancer Research, Purdue University, West Lafayette, IN 47907, USA

Introduction
Bio
Dr. Andrea Kasinski is a Full Professor in Biological Sciences at Purdue University, Deputy Director of the Purdue Institute for Cancer Research, and Co-Founder and CEO of LigamiR Therapeutics. She earned her Ph.D. in Molecular Genetics from Emory University under the mentorship of Dr. Haian Fu before completing her postdoctoral training with Dr. Frank J. Slack at Yale University, where she focused on microRNA biology. In 2013, she joined Purdue University as a tenure-track faculty member in the Department of Biological Sciences. Dr. Kasinski’s research focuses on uncovering epigenetic mechanisms in cancer and translating these insights into novel therapeutics. She was among the first to demonstrate that therapeutic microRNAs can be effectively delivered without protective carriers, reducing the toxic side effects associated with traditional delivery vehicles. Additionally, she pioneered the development of a fully modified version of the tumor-suppressive microRNA, miR-34a—findings that have resulted in her establishing LigamiR Therapeutics, which she will highlight in her presentation.

Registration

This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar.  Registrations with academic institutional email addresses will be prioritized.

Certificates of attendance will be delivered to those who attend the live webinar.


Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.

Program

Speaker/Presentation Time in CEST Time in EDT

Chair Introduction

Dr. Laura Poliseno

5:00 -5:05 pm 11:00-11:05 am

From MicroRNA Biology to Clinical Breakthroughs: Advancing MicroRNAs as Anti-Cancer Agents

Prof. Dr. Andrea L. Kasinski

5:05 - 5:45 pm 11:05 - 11:45 am
Q&A 5:45 - 5:55 pm 11:45-11:55 am

Closing of Webinar

Dr. Laura Poliseno

5:55 - 6:00 pm 11:55 - 12:00 pm

Relevant Special Issue

Non-Coding RNA: 10th Anniversary
Edited by Prof. Dr. George A. Calin
Deadline for submission: 31 March, 2026

Sponsors and Partners

Organizers

Top